129 related articles for article (PubMed ID: 25912145)
21. [Retinal astrocytic hamartomas].
Sauvan L; Sampo M; Stolowy N; Matonti F; Hoffart L
J Fr Ophtalmol; 2017 May; 40(5):442-443. PubMed ID: 28478017
[No Abstract] [Full Text] [Related]
22. Efficacy of Rapamycin in Tuberous Sclerosis-Associated Hypopigmented Macules: Back to the Future.
Arbiser JL
JAMA Dermatol; 2015 Jul; 151(7):703-4. PubMed ID: 25692853
[No Abstract] [Full Text] [Related]
23. Treatment of Aggressive Retinal Astrocytic Hamartoma with Oral Mechanistic Target of Rapamycin Inhibition.
Wu F; McGarrey MP; Geenen KR; Skalet AH; Guillot FH; Wilson JL; Shah AS; Gonzalez E; Thiele EA; Kim IK; Aronow ME
Ophthalmol Retina; 2022 May; 6(5):411-420. PubMed ID: 35007768
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of an isolated retinal astrocytic hamartoma aided by optical coherence tomography.
Kimoto K; Kishi D; Kono H; Ikewaki J; Shinoda K; Nakatsuka K
Acta Ophthalmol; 2008 Dec; 86(8):921-2. PubMed ID: 19086931
[No Abstract] [Full Text] [Related]
25. Indocyanine green angiography of retinal astrocytomas associated with tuberous sclerosis.
Koak N; Saatci AO; Kaynak S; Ergin MH; Ingil GC
Korean J Ophthalmol; 2003 Dec; 17(2):145-8. PubMed ID: 14717494
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous regression of retinal astrocytic hamartoma in a patient with tuberous sclerosis.
Kiratli H; Bilgiç S
Am J Ophthalmol; 2002 May; 133(5):715-6. PubMed ID: 11992878
[TBL] [Abstract][Full Text] [Related]
27. Retinal astrocytic hamartoma and systemic spectrum of disease in successive generations with tuberous sclerosis complex.
Sood G; Samanta R; Pandurangan S; Sharma P; Singh A; Agrawal A
Indian J Ophthalmol; 2020 Nov; 68(11):2504-2507. PubMed ID: 33120658
[No Abstract] [Full Text] [Related]
28. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.
Jozwiak J; Jozwiak S; Oldak M
Med Res Rev; 2006 Mar; 26(2):160-80. PubMed ID: 16329102
[TBL] [Abstract][Full Text] [Related]
29. Retinal astrocytic hamartoma in tuberous sclerosis complex in an elderly person: a case report.
Qin X; Tao Y; Zhang Z
BMC Ophthalmol; 2018 Dec; 18(1):319. PubMed ID: 30541513
[TBL] [Abstract][Full Text] [Related]
30. Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis.
Cabrera López C; Martí T; Catalá V; Torres F; Mateu S; Ballarín Castán J; Torra Balcells R
Nefrologia; 2011; 31(3):292-8. PubMed ID: 21629335
[TBL] [Abstract][Full Text] [Related]
31. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
Wienecke R; Fackler I; Linsenmaier U; Mayer K; Licht T; Kretzler M
Am J Kidney Dis; 2006 Sep; 48(3):e27-9. PubMed ID: 16931204
[TBL] [Abstract][Full Text] [Related]
32. Retinal astrocytic hamartoma-ophthalmologic marker of tuberous sclerosis.
Radhakrishnan DM; Jose A; Kumar N; Warrier AR; Shree R
QJM; 2019 Jun; 112(6):451-452. PubMed ID: 30541150
[No Abstract] [Full Text] [Related]
33. Orbital fibrosis syndrome associated with combined retinal hamartoma.
Saffra NA; Strauss DS; Saint-Louis LA; Rosenberg S
Can J Ophthalmol; 2011 Aug; 46(4):367-8. PubMed ID: 21816259
[No Abstract] [Full Text] [Related]
34. Surgical outcomes of epiretinal membranes associated with combined hamartoma of the retina and retinal pigment epithelium.
Cohn AD; Quiram PA; Drenser KA; Trese MT; Capone A
Retina; 2009 Jun; 29(6):825-30. PubMed ID: 19276871
[TBL] [Abstract][Full Text] [Related]
35. Tuberous sclerosis: ocular findings and their correlation with cranial computed tomography.
Gelişken F; Gelişken O; Sadikoglu Y
Bull Soc Belge Ophtalmol; 1990; 238():111-21. PubMed ID: 2131114
[TBL] [Abstract][Full Text] [Related]
36. Astrocytic hamartoma: a case report.
Yudcovitch LB; Lahiff JM; Ochiltree AJ
Clin Exp Optom; 2008 Mar; 91(2):187-92. PubMed ID: 18271783
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and therapeutic challenges.
Cohen SM; Reichel E; Arroyo JG; Lujan BJ
Retina; 2011 Apr; 31(4):806-9. PubMed ID: 22141148
[No Abstract] [Full Text] [Related]
38. Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema.
Saito W; Kase S; Ohgami K; Mori S; Ohno S
Acta Ophthalmol; 2010 May; 88(3):377-80. PubMed ID: 18778334
[TBL] [Abstract][Full Text] [Related]
39. [Ocular manifestations of tuberous sclerosis].
Urban B; Bakunowicz-Łazarczyk A
Klin Oczna; 2001; 103(1):47-50. PubMed ID: 11605586
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of astrocytic hamartoma of the optic disc associated with gyrate atrophy.
Sebrow DB; Jung JJ; Dagi Glass LR; Horowitz J; Chang S
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):387-90. PubMed ID: 25856828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
